Lv7303
4280 积分 2023-12-06 加入
Rational Design of PROTAC Degraders and Their Spatiotemporal Controlled Delivery for Enhanced Tumor Penetration and PD-L1 Protein Degradation
21小时前
已完结
Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer
4天前
已完结
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN
16天前
已完结
Proteolysis Targeting Chimeras With Reduced Off-targets
16天前
已完结
Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific PeptideDrug Conjugates
2个月前
已关闭
Blocking SKI-1 to rescue the blood–brain barrier and improve stroke recovery
2个月前
已完结
Healthy aging and the blood–brain barrier
2个月前
已完结
Discovery of tert-Butyl Ester Based 6-Diazo-5-oxo-l-norleucine Prodrugs for Enhanced Metabolic Stability and Tumor Delivery
2个月前
已完结
A Lipid Prodrug Strategy Enhances Targeted Protein Degrader CNS Pharmacokinetics
2个月前
已完结
Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration
3个月前
已完结
皖公网安备34019202002308
